1. Home
  2. FRPH vs ASMB Comparison

FRPH vs ASMB Comparison

Compare FRPH & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FRP Holdings Inc.

FRPH

FRP Holdings Inc.

HOLD

Current Price

$23.27

Market Cap

420.6M

Sector

Finance

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$24.49

Market Cap

442.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRPH
ASMB
Founded
1986
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
420.6M
442.9M
IPO Year
1995
2010

Fundamental Metrics

Financial Performance
Metric
FRPH
ASMB
Price
$23.27
$24.49
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$44.20
AVG Volume (30 Days)
79.2K
179.9K
Earning Date
04-10-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.78
EPS
N/A
N/A
Revenue
$42,846,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$638.39
P/E Ratio
N/A
N/A
Revenue Growth
2.57
N/A
52 Week Low
$20.53
$15.25
52 Week High
$27.98
$39.71

Technical Indicators

Market Signals
Indicator
FRPH
ASMB
Relative Strength Index (RSI) 62.16 36.04
Support Level $23.10 $20.23
Resistance Level $24.59 $31.21
Average True Range (ATR) 0.70 1.80
MACD 0.12 -0.30
Stochastic Oscillator 90.51 2.96

Price Performance

Historical Comparison
FRPH
ASMB

About FRPH FRP Holdings Inc.

FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, industrial, and office (the Development Segment), and (iv) management of mixed-use residential/retail properties owned through joint ventures.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Share on Social Networks: